#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency common variable Spinal muscular atrophy Candida infection Gaucher's disease type I Transplant rejection Necrotising enterocolitis neonatal Myxoid liposarcoma Dermatomyositis Non-small cell lung cancer Vascular calcification Ataxia telangiectasia Thalassaemia Acute lymphocytic leukaemia recurrent Ventricular fibrillation Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Diagnostics Thrombotic thrombocytopenic purpura – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Treatment Rhabdomyosarcoma – Diagnostics Congenital generalised lipodystrophy – Trials in Disease Vascular malformation – Trials in Disease Breast angiosarcoma – Trials in Disease Niemann-Pick disease Gaucher’s disease type I Propionic acidaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZIRCONIUM (89ZR) GIRENTUXIMAB Emraclidine Bexotegrast Ficlatuzumab Atezolizumab Ladarixin Gskvx000000008866 Gsk4004280 Venglustat Oxytocin Synthetic Lactose Monohydrate Codeine Phosphate Izorlisib Mesilate Mecillinam Mbf-015 Rituximab Specific Nucleic Acid Sna-Veru R2R01 Litifilimab Blood And Related Products More therapies…

    Learn about Your Condition

    Thrombectomy Metastatic neoplasm Desmoplastic melanoma Fibrosarcoma Bipolar disorder Psychotic disorder Basal cell naevus syndrome Pigmentary glaucoma Rhabdoid tumour Colorectal cancer metastatic Cardiovascular disorder Milk allergy Pyelonephritis acute Spinal muscular atrophy Eclampsia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypercholesterolaemia

  • Study of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Ezetimibe
    Spain

  • Study on the Effect of Genetic Testing and Training on Muscle Side Effects in Patients Taking Statins for Cardiovascular Risk Prevention

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    • Primary hypercholesterolaemia
    Investigated Drugs:
    • Fluvastatin Sodium
    • Pitavastatin Calcium
    • Rosuvastatin Zinc
    Spain

  • Study on the Effects and Safety of MK-0616 for Adults with High Cholesterol

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Mk-0616
    Germany Italy Spain

  • Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Bulgaria Czechia Germany Hungary Poland Slovakia +1

  • Study on MK-0616, Ezetimibe, and Bempedoic Acid for Adults with High Cholesterol

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Bempedoic Acid
    • Ezetimibe
    • Enlicitide Chloride
    France Spain

  • Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Enlicitide Chloride
    Czechia Finland France Germany Hungary Italy +3
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!